Pre Radiotherapy Daily Exercise Training in Non-Small Cell Lung Cancer (PRIME)
PRIME - Pre Radiotherapy Daily Exercise Training in Non-Small Cell Lung Cancer
Sponsor: Rigshospitalet, Denmark
A NA clinical study on Chemoradiation and Non-Small Cell Lung Cancer Stage, this trial is ongoing. The trial is conducted by Rigshospitalet, Denmark and has accumulated 10 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Oct 2024 — Present [monthly]
Unknown NA
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Oct 2024 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Apr 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Apr 2021 — Apr 2023 [monthly]
Active Not Recruiting NA
▶ Show 5 earlier versions
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Apr 2019 — Nov 2020 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Apr 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Apr 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Rigshospitalet, Denmark
- University of Copenhagen
For direct contact, visit the study record on ClinicalTrials.gov .